Problems with current medications
Paclitaxel, the active medicine in Taxolcur Increase font size so this is easier to read, is an FDA-approved and effective ‘first-line’ cancer therapy for many human cancers. Until now, it has not been available to treat dogs because of serious side-effects with current human dosage forms and attempts by others to overcome this have failed. Until now…
We have solved the dosage form and provide a safe, well-tolerated and effective medicine to dogs for the first time.*
Existing formulation is very toxic.
It has many side effects.
Dose is not optimal.
Poor bioavailability.
Long administration time at doctors site.
Upon approvals, Taxolcur will be marketed as PacCur-vet®
**These statements have not been definitively proven and are the subject of our ongoing development through the FDA process
.jpg)
.png)